News NewsOur Company DuPont Nutrition & Biosciences to Showcase Innovative Ingredient Solutions at SupplySide West New innovations range from plant-based capsule delivery mechanisms to premium probiotic formulations for cognitive health WILMINGTON, Del.,...
ROCHESTER, N.Y., July 15, 2019 – DuPont (NYSE: DD) today announced the opening of a new state-of-the-art probiotics fermentation unit at its Rochester, New York, facility. Construction of the unit was completed in March as part of an overall $100MM investment to expand probiotics capacity. The facility is now producing high-quality probiotics for the dietary supplement and food and beverage industries, which have the potential to provide health benefits to consumers of all ages.
WILMINGTON, Del., April 25, 2019 – It is estimated that nearly 3 million newborns and 1.2 million children suffer from sepsis globally each year1, with limited effective forms of prevention currently available. To help combat this, DuPont Nutrition & Biosciences (DuPont), the global leader in probiotics, will provide clinical trial probiotic and prebiotic products to the Centre for Global Child Health at The Hospital for Sick Children (SickKids) in Toronto for its research on the effects of probiotics on sepsis in infants.
ROCHESTER, NY, March 28, 2019 – DuPont today announced it has completed construction on a new, state-of-the art probiotics fermentation unit at its Rochester, New York, facility. The unit, now largest in the world, is part of a multiphase nearly $100 million investment to expand probiotics capacity and enhance the company’s leadership in delivering high-quality, clinically documented probiotics to dietary supplement and food and beverage manufacturers.
DuPont Releases Clinical Study Results that Demonstrate Benefits of High-Potency, Multi-Strain Probiotic Formulations
KANTVIK, Finland, March 21, 2019 – Results from a clinical trial performed by Taverniti and colleagues from the University of Milan (IT) suggest that ingesting higher doses of multispecies probiotic formulations may permit higher, earlier and longer recovery of probiotics in feces of healthy adults.
杜邦是一个以科研为基础的全球企业。杜邦营养与健康事业部致力于益生菌产品的开发与研究。 位于芬兰的健康营养研究中心为杜邦全球益生菌功效提供研究支持，特有的ENTEROMIXTM仿生试验技术能够模拟人体肠道环境，跟踪和研究益生菌和益生元在人体消化道中的真正表现。凭借这个中心，我们也一跃成为全球唯一拥有健康营养研究中心的菌种供应商。 在美国，我们的科学研究中心对益生菌生产技术、微生物基因组学及微生物学，以及产品稳定性进行充分研究和实践。在丹麦，杜邦科学家们致力于分析学及代谢组学临床研究。